Pretreatment with granulocyte colony-stimulating factor reduces myelopoiesis in irradiated mice

Radiation Research

Volumn 151, Issue 3, 1999, Pages 363-367

  Pospisil M ^a   Hofer, M ^a   Netikova J ^a   Hola J ^a   Znojil, V ^b   Vacha J ^b   Vacek, A ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT 60; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; COLONY FORMING UNIT GM; CONTROLLED STUDY; ERYTHROPOIESIS; FEMUR; GAMMA IRRADIATION; GRANULOCYTE; GRANULOPOIESIS; MALE; MOUSE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; SPLEEN; SUBCUTANEOUS DRUG ADMINISTRATION; WHOLE BODY RADIATION;

ANIMALIA;

EID: 0345491058     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579949     Document Type: Article

References (19)

1. R. Neta, J. J. Oppenheim and S. D. Douches, Interdependence of the radioprotective effects of human recombinant interleukin 1α, tumor necrosis factor α, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor. J. Immunol. 140, 108-111 (1988).
2. R. Neta and J. J. Oppenheim, Cytokines in therapy of radiation injury. Blood 72, 1093-1095 (1988).
3. S. Tanikawa, I. Nakao, K. Tsuneoka and N. Nara, Effects of recombinant granulocyte colony-stimulating factor (rG-CSF) and recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) on acute radiation hematopoietic injury in mice. Exp. Hematol. 17, 883-888 (1989).
4. M. L. Patchen, T. J. MacVittie, B. D. Solberg and L. M. Souza, Therapeutic administration of recombinant human granulocyte colony-stimulating factor accelerates hemopoietic regeneration and enhances survival in a murine model of radiation-induced myelosuppression. Int. J. Cell Cloning 8, 107-122 (1990).
5. F. M. Uckun, L. Souza, K. G. Waddick, M. Wick and C. W. Song, In vivo radioprotective effects of recombinant human granulocyte colony-stimulating factor in lethally irradiated mice. Blood 75, 638-645 (1990).
6. K. G. Waddick, C. W. Song, L. Souza and F. M. Uckun, Comparative analysis of the in vivo radioprotective effects of recombinant granulocyte colony-stimulating factor (G-CSF), recombinant granulocyte-macrophage CSF, and their combination. Blood 77, 2364-2371 (1991).
7. 1 mice. Exp. Hematol. 21, 1605-1607 (1993).
8. M. Pospíšil, M. Hofer, V. Znojil, J. Vácha, J. Netíková and J. Holá, Synergistic effects of granulocyte colony-stimulating factor and drugs elevating extracellular adenosine on neutrophil production in mice. Blood 86, 3692-3697 (1995).
9. P. Quesenberry, K. Zuckerman, M. Ryan and F. Stohlman, Jr., A dichotomy between the release of bone marrow granulocytes and stem cells. Proc. Soc. Exp. Biol. Med. 154, 53-56 (1977).
10. F. M. Uckun, S. Gillis, L. Souza and C. W. Song, Effects of recombinant growth factors on radiation survival of human bone marrow progenitor cells. Int. J. Radiat. Oncol. Biol. Phys. 16, 415-435 (1989).
11. M. A. S. Moore, Does stem cell exhaustion result from combining hematopoietic growth factors with chemotherapy? If so, how do we prevent it? Blood 80, 3-7 (1992).
12. M. Aglietta, W. Piacibello, F. Sanavio, A. Stacchini, F. Aprá, M. Schena, C. Mossetti, F. Carnino, F. Caligaris-Cappio and F. Gavosto, Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor. J. Clin. Invest. 83, 551-557 (1989).
13. S. Vadhan-Raj, H. E. Broxmeyer, W. N. Hittelman, N. E. Papadopoulos, S. P. Chawla, C. Fenoglio, S. Cooper, E. S. Buescher, R. W. Frenck and R. S. Benjamin, Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level. J. Clin. Oncol. 10, 1266-1277 (1992).
14. H. E. Broxmeyer, L. Benninger, S. R. Patel, R. S. Benjamin and S. Vadhan-Raj, Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor. Exp. Hematol. 22, 100-102 (1994).
15. R. Neta, J. R. Keller, N. Ali, F. Blanchette and C. M. Dubois, Contrasting mechanisms of the myeloprotective effects of interleukin-1 against ionizing radiation and cytotoxic 5-fluorouracil. Radiat. Res. 145, 624-631 (1996).
16. G. Molineux and T. M. Dexter, A comparison of hematopoiesis in normal and splenectomized mice treated with granulocyte colony-stimulating factor. Blood 75, 563-569 (1990).
17. B. Bungart, M. Loeffler, H. Goris, B. Dontje, V. Diehl and W. Nijhof, Differential effects of recombinant human colony stimulating factor (rhG-CSF) on stem cells in marrow, spleen and peripheral blood in mice. Br. J. Haematol. 76, 174-179 (1990).
18. N. Drize, O. Gan and A. Zander, Effect of recombinant human granulocyte colony-stimulating factor treatment of mice on spleen colony-forming unit number and self-renewal capacity. Exp. Hematol. 21, 1289-1293 (1993).
19. J. L. Curry and J. J. Trentin, Hemopoietic spleen colony studies: I. Growth and differentiation. Dev. Biol. 15, 395-413 (1967).